| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |